Expanding the chemical and therapeutic landscape of 5H-Indeno[1,2-b]pyridin-5-one derivatives: Novel anticancer activity, EGFR inhibition, and modulation of HIF–VEGF and PI3K/AKT/mTOR pathways supported by computational insights
Fields of Study & Subjects
Cancer
Hypoxia
and Metabolism
Lung Cancer Treatments and Mutations
Cytokine Signaling Pathways and Interactions
Publication details
- Journal / source
- Bioorganic Chemistry
- Publisher
- Elsevier BV
- Volume
- 170
- Pages
- 109476–109476
- Publication date
- 7 January 2026
- Language
- EN